RxDoctor Payments Data

Christian Schmidt, MD

Surgery · Indianapolis, INNPI 1417915067

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Stryker at 47.0% of the total. Reporting peaked in 2023 at $757 and has fallen 52.0% since, to $363 in 2025. That places this record below the midpoint for surgery clinicians in IN, where the typical reported total is $1,566.

$1,329in general payments, 2019–2025

Across 17 payments — averaging $78.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$625
  • Linvatec Corporation$262
  • Anika Therapeutics, Inc.$139
  • Sanara Medtech Inc.$127
  • Coastal Medical Technologies LLC$56
  • Heron Therapeutics, Inc.$51
  • plus $69 from 3 others
$256,078in research payments, 2019–2025

Across 50 payments — averaging $5121.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$256K

What the payments were for

  • Food & beverage$1,329100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,329 in reported general payments places this provider in the 45th percentile of 524 surgery providers in Indiana.

See all surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$96,830
Medicare patients
155
Services billed
258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase93$316,687
Pantoprazole Sodium15$114

Paid to pharmacies, not to this prescriber.

Other surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →